Search

Your search keyword '"Yopp, Adam"' showing total 1,069 results

Search Constraints

Start Over You searched for: Author "Yopp, Adam" Remove constraint Author: "Yopp, Adam"
1,069 results on '"Yopp, Adam"'

Search Results

53. Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group

54. Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.

55. Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.

58. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?

59. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.

60. Actual 10-year survivors following resection of adrenocortical carcinoma.

70. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database

72. Demographic and social vulnerability factors associated with late diagnosis of gastrointestinal cancers.

75. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.

76. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.

77. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

78. Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival.

79. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence

80. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes

81. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients

83. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

84. Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.

87. Neutrophil‐lymphocyte and platelet‐lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma

95. Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases

Catalog

Books, media, physical & digital resources